| [1] | Chi ZL, Hayasaka Y, Zhang XY, Cui HS, Hayasaka S (2007) S100A9-positive granulocytes and monocytes in lipopolysaccharide-induced anterior ocular inflammation. Exp Eye Res 84: 254–265.
|
| [2] | Lee DH, Kim JK, Joo CK (2005) Translocation of nuclear factor-kappaB on corneal epithelial cells induced by ultraviolet B irradiation. Ophthalmic Res 37: 83–88.
|
| [3] | Li T, Lu L (2007) Functional role of CCCTC binding factor (CTCF) in stress-induced apoptosis. Experimental Cell Research 313: 3057v3065.
|
| [4] | Lu L (2006) Stress-induced corneal epithelial apoptosis mediated by K+ channel activation. Prog Retin Eye Res 25: 515–538.
|
| [5] | Miyamoto T, Saika S, Ueyama T, Okada Y, Shirai K, et al. (2006) Cyclooxygenase 2 expression in rat corneas after ethanol exposure. J Cataract Refract Surg 32: 1736–1740.
|
| [6] | Zhang MC, Wang Y, Yang Y (2006) The expression of nuclear factor kappa B in inflammation-induced rat corneal neovascularization. Ocul Immunol Inflamm 14: 359–365.
|
| [7] | Xu KP, Ding Y, Ling J, Dong Z, Yu FS (2004) Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest Ophthalmol Vis Sci 45: 813–820.
|
| [8] | Li T, Lu L (2005) Epidermal growth factor-induced proliferation requires down-regulation of Pax6 in corneal epithelial cells. J Biol Chem 280: 12988–12995.
|
| [9] | Lu L, Reinach PS, Kao WW (2001) Corneal epithelial wound healing. Exp Biol Med (Maywood) 226: 653–664.
|
| [10] | Yin J, Yu FS (2009) ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. Invest Ophthalmol Vis Sci 50: 132–139.
|
| [11] | Lu L, Wang L, Shell B (2003) UV-induced signaling pathways associated with corneal epithelial cell apoptosis. Invest Ophthalmol Vis Sci 44: 5102–5109.
|
| [12] | Baniahmad A, Steiner C, Kohne AC, Renkawitz R (1990) Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Cell 61: 505–514.
|
| [13] | Bell KD, Campbell RJ, Bourne WM (2000) Pathology of late endothelial failure: late endothelial failure of penetrating keratoplasty: study with light and electron microscopy. Cornea 19: 40–46.
|
| [14] | Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, et al. (2000) CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405: 486–489.
|
| [15] | Lu L, Wang L, Li T, Wang J (2010) NF-kappaB subtypes regulate CCCTC binding factor affecting corneal epithelial cell fate. J Biol Chem 285: 9373–9382.
|
| [16] | Cristofanon S, Morceau F, Scovassi AI, Dicato M, Ghibelli L, et al. (2009) Oxidative, multistep activation of the noncanonical NF-kappaB pathway via disulfide Bcl-3/p50 complex. Faseb J 23: 45–57.
|
| [17] | Khan KA, Coaquette A, Davrinche C, Herbein G (2009) Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages. J Immunol 182: 7784–7794.
|
| [18] | Watanabe S, Tanizaki M, Kaneko A (1997) Two types of stretch-activated channels coexist in the rabbit corneal epithelial cell. EXPERIMENTAL EYE RESEARCH 64: 1027–1035.
|
| [19] | Crossen PE (1989) Cytogenetic and molecular changes in chronic B-cell leukemia. Cancer Genet Cytogenet 43: 143–150.
|
| [20] | Ohno H, Takimoto G, McKeithan TW (1990) The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60: 991–997.
|
| [21] | Brocke-Heidrich K, Ge B, Cvijic H, Pfeifer G, Loffler D, et al. (2006) BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription. Oncogene 25: 7297–7304.
|
| [22] | Franzoso G, Bours V, Azarenko V, Park S, Tomita-Yamaguchi M, et al. (1993) The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. Embo J 12: 3893–3901.
|
| [23] | Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D (1993) The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev 7: 1354–1363.
|
| [24] | Hishiki T, Ohshima T, Ego T, Shimotohno K (2007) BCL3 acts as a negative regulator of transcription from the human T-cell leukemia virus type 1 long terminal repeat through interactions with TORC3. J Biol Chem 282: 28335–28343.
|
| [25] | Kabuta T, Hakuno F, Cho Y, Yamanaka D, Chida K, et al. (2010) Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-kappaB activity. Biochem Biophys Res Commun 394: 697–702.
|
| [26] | Kashatus D, Cogswell P, Baldwin AS (2006) Expression of the Bcl-3 proto-oncogene suppresses p53 activation. Genes Dev 20: 225–235.
|
| [27] | Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R (2006) Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell 125: 665–677.
|
| [28] | Palmer S, Chen YH (2008) Bcl-3, a multifaceted modulator of NF-kappaB-mediated gene transcription. Immunol Res 42: 210–218.
|
| [29] | Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132: 344–362.
|
| [30] | Lu L, Wang L, Li T, Wang JNF-kappaB subtypes regulate CCCTC binding factor affecting corneal epithelial cell fate. J Biol Chem 285: 9373–9382.
|
| [31] | Keutgens A, Robert I, Viatour P, Chariot A (2006) Deregulated NF-kappaB activity in haematological malignancies. Biochem Pharmacol 72: 1069–1080.
|
| [32] | Xiao W (2004) Advances in NF-kappaB signaling transduction and transcription. Cell Mol Immunol 1: 425–435.
|
| [33] | Yang J, Williams RS, Kelly DP (2009) Bcl3 interacts cooperatively with peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator 1alpha to coactivate nuclear receptors estrogen-related receptor alpha and PPARalpha. Mol Cell Biol 29: 4091–4102.
|
| [34] | Kang SM, Tran AC, Grilli M, Lenardo MJ (1992) NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science 256: 1452–1456.
|
| [35] | Neumann M, Naumann M (2007) Beyond IkappaBs: alternative regulation of NF-kappaB activity. Faseb J 21: 2642–2654.
|
| [36] | Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18: 2195–2224.
|
| [37] | Thornburg NJ, Raab-Traub N (2007) Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes. J Virol 81: 12954–12961.
|
| [38] | Zhang Q, Didonato JA, Karin M, McKeithan TW (1994) BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins. Mol Cell Biol 14: 3915–3926.
|
| [39] | Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, et al. (1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 359: 339–342.
|
| [40] | Wang L, Li T, Lu L (2003) UV-induced corneal epithelial cell death by activation of potassium channels. Invest Ophthalmol Vis Sci 44: 5095–5101.
|
